People group with a high risk of colorectal cancer

Share This Post

What is the disease of rectal cancer?

Colorectal cancer is one of the five most common cancers in the world. The other four types of cancer are lung cancer, breast cancer, prostrate cancer and oral cancer.

These five high-risk cancers, except lung cancer, the remaining four are all malignant tumors of the digestive system. Moreover, experts said that the incidence of gastric cancer, esophageal cancer, and liver cancer has stabilized, but the incidence of colorectal cancer has increased significantly, and there is a trend of rejuvenation.

In 2015, the incidence of colorectal cancer in India accounted for 24.3% of the world’s total, and the number of deaths accounted for 22.9% of the world. Compared with 2005, the number of new cases and deaths have doubled in ten years, reaching 377,000 and 191,100 respectively.

Factor for colorectal cancer increase

In addition to genetic factors, the rejuvenation of colorectal cancer is also an important reason for increased urbanization and changes in the diet structure of the population. Urban white-collar workers under high-intensity work pressure are particularly worthy of attention.

The reason for the rapid increase in colorectal cancer incidence is closely related to the diet structure.

Think about what we usually eat, high-fat, high-protein, high-calorie foods account for a large proportion, and many people are seriously inadequate intake of vegetables and fruits.

Secondly, there is less exercise, more obesity, and a longer sitting time. Many people are almost facing the computer or playing mobile phones every day except for the time of sleeping, and the exercise time is seriously insufficient. These are all the causes of the increasing incidence of colorectal cancer.
6 high-risk groups of colorectal cancer
People with a family history
People who like to eat high-fat and high-protein foods
People with long-term constipation and bloody stools
People suffering from intestinal diseases, cholecystitis and other related chronic diseases
People with chronic depression
People who stay up all night
These high-risk groups are over 50 years old, at least one intestinal examination should be done annually, and those under 50 years old should also have an intestinal examination every 2 to 3 years.

Rectal cancer symptoms

The most obvious is blood in the stool. Most other symptoms are also likely to accompany bowel movements, including constipation, thin stools, heavy back pain (despite extreme exertion during bowel movements, the stool is difficult to resolve, accompanied by pain), abdominal pain and so on. However, there are many cases where the cancer is so severe that symptoms do not appear.

In addition, it is not uncommon to mistake rectal cancer for hemorrhoids. Until the abdominal bloating becomes stronger and intestinal obstruction occurs, it is finally found that it is rectal cancer. Take a step back and say that even hemorrhoids can’t be ignored. In fact, this group of people with hemorrhoids is a group with a high incidence of rectal cancer.

If you notice symptoms such as bloody stools or abnormal bowel movements, you must go to the hospital in time for examination.

Most colorectal cancer can be prevented

In addition to genetic immutability, most colorectal cancers can be prevented by changes in lifestyle and eating habits. Especially for digestive tract tumors, the relationship with eating is very close.

Studies have shown that 50% of colorectal cancer in the United States can be prevented by adjusting diet, weight control, and exercise.

Recently, authoritative cancer nutrition experts in the United States have given six ways to prevent colorectal cancer, which can help reduce the risk of colon cancer.

1 Control belly fat. Regardless of body weight, the correlation between abdominal fat and colorectal cancer risk also exists.
2 Regular exercise regularly. You don’t have to go to the gym, you can clean the room, you can also go out for a run, in short, you must move.
3 Eat more high-fiber foods. For every 10 grams of fiber added to your daily diet, you can reduce your colon cancer risk by 10%.
4 Eat less red meat and processed meat. At the same weight, processed meats such as hot dogs, bacon, sausages and cooked meat products will increase the risk of colon cancer even more.
5 Do not drink or drink less.
6 Eat more garlic. Evidence suggests that a diet rich in garlic can reduce the risk of colorectal cancer.
In addition, experts suggest that you should eat less or not foods rich in saturated fat and cholesterol, including: big fish, meat, oil, animal offal, egg yolk, etc .; vegetable oils, including peanut oil, soybean oil, rapeseed oil, etc. are limited to everyone About 20 to 30 grams per day, about 2 to 3 tablespoons. Do not eat or eat less fried, fried, grilled food.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient A case report
CAR T-Cell therapy

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient : A case report

Claudin18.2-targeted CAR-T cell therapy has shown remarkable potential in treating advanced pancreatic cancer, as highlighted in a recent case report. This innovative approach led to complete remission in a patient with advanced disease, underscoring the promise of targeted immunotherapy. By leveraging the specific expression of Claudin18.2 on cancer cells, this therapy offers a precision-based treatment, heralding a new era in pancreatic cancer management with significant clinical implications.

What is the treatment after BCMA CAR T failed in RR multiple myeloma cases
CAR T-Cell therapy

What is the treatment after BCMA CAR T failed in R/R multiple myeloma cases?

For people with relapsed or refractory multiple myeloma, BCMA CAR T-cell therapy might not work. Other treatments, such as bispecific antibodies, other CAR T-cell therapies that target different antigens, and combination regimens with immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, can still be used. OriCAR-017 is another immunotherapy that is under trial and is expected to be launched soon. Clinical trials offer experimental treatments, providing access to novel therapies. Tailored approaches based on patient-specific factors and emerging research are crucial for improving outcomes in this challenging scenario.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy